Integrating Biocon Biologics will simplify its corporate structure and strengthen Bengalaru, India-based Biocon’s position in ...

Biocon merges with Biocon Biologics in a $5.5B deal; find out how this impacts investors and share prices today!

The optimism stems from the company's plan to increase its stake in Biocon Biologics (BBL), the expected consolidation of the ...

Kiran Mazumdar-Shaw-led Biocon Ltd has engaged four investment banks as advisors as the leading global bio-pharmaceutical ...

JP Morgan maintains a neutral stance on Bajaj Finance, citing strategic growth plans and market share ambitions. Goldman ...

As part of this announcement, Biocon's board has also approved raising funds to the tune of ₹4,500 crore through a Qualified ...

The transaction accelerates the expiration of biosimilars non-compete restrictions, the company said.

Biocon plans to buy the remaining shares of its subsidiary, Biocon Biologics Limited, by exchanging its own shares. This deal ...

The shares of the company closed at Rs 381.60 apiece on Monday, the lowest level seen by the stock in over three weeks.

Biocon Limited ( ($IN:BIOCON) ) has shared an announcement. Biocon Limited announced that India Ratings and Research has assigned and affirmed ...

Biocon Executive Chairperson Kiran Mazumdar-Shaw stressed that the business remains professionally run and the company’s ...

Brokerages say Biocon's move to fully acquire Biocon Biologics simplifies structure and unlocks value, but near-term stock ...